MKI67 and neoplasm: Since it is still unclear which patient ultimately benefits from which treatment option [4,18,19], the authors want to evaluate the role of Ki67 tumor expression as a prognostic and predictive parameter in PM in times of modern lung-sparing surgery—especially after the MARS 2 trial questioned the role of surgery in PM in general [20].